Evidence map›Paper›PMID 36315645›Full record

ArticleBrain : a journal of neurology2023

Mnk1/2 kinases regulate memory and autism-related behaviours via Syngap1.

Kleanthi Chalkiadaki, Mehdi Hooshmandi, Gilliard Lach, Elpida Statoulla, Konstanze Simbriger, Ines S Amorim, Stella Kouloulia, Maria Zafeiri, Panagiotis Pothos, Éric Bonneil and 10 more

Open access · greenAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 5 countries.

Kleanthi ChalkiadakiBiomedical Research Institute, Foundation for Research and Technology-Hellas, University Campus, 45110 Ioannina, Greece.
Mehdi HooshmandiDepartment of Anesthesia and Alan Edwards Centre for Research on Pain, McGill University, Montréal H3A 0G1, Canada.
Gilliard LachCentre for Discovery Brain Sciences and The Patrick Wild Centre, University of Edinburgh, Edinburgh EH8 9XD, UK.
Elpida StatoullaBiomedical Research Institute, Foundation for Research and Technology-Hellas, University Campus, 45110 Ioannina, Greece.
Konstanze SimbrigerCentre for Discovery Brain Sciences and The Patrick Wild Centre, University of Edinburgh, Edinburgh EH8 9XD, UK.
Ines S AmorimCentre for Discovery Brain Sciences and The Patrick Wild Centre, University of Edinburgh, Edinburgh EH8 9XD, UK.
Stella KoulouliaCentre for Discovery Brain Sciences and The Patrick Wild Centre, University of Edinburgh, Edinburgh EH8 9XD, UK.
Maria ZafeiriBiomedical Research Institute, Foundation for Research and Technology-Hellas, University Campus, 45110 Ioannina, Greece.
Panagiotis PothosBiomedical Research Institute, Foundation for Research and Technology-Hellas, University Campus, 45110 Ioannina, Greece.
Éric BonneilInstitute for Research in Immunology and Cancer, Université de Montréal, Station Centreville, Montréal H3C 3J7, Canada.
Ilse GantoisGoodman Cancer Institute and Biochemistry Department, McGill University, Montréal H3A 1A3, Canada.
Jelena PopicGoodman Cancer Institute and Biochemistry Department, McGill University, Montréal H3A 1A3, Canada.
Sung-Hoon KimGoodman Cancer Institute and Biochemistry Department, McGill University, Montréal H3A 1A3, Canada.
Calvin WongDepartment of Anesthesia and Alan Edwards Centre for Research on Pain, McGill University, Montréal H3A 0G1, Canada.
Ruifeng CaoDepartment of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN 55812, USA.
Noboru H KomiyamaSimons Initiative for the Developing Brain, University of Edinburgh, Edinburgh EH8 9XD, UK.
Yaser AtlasiPatrick G. Johnston Centre for Cancer Research, Queen's University of Belfast, Belfast BT9 7AE, Northern Ireland, UK.
Seyed Mehdi JafarnejadPatrick G. Johnston Centre for Cancer Research, Queen's University of Belfast, Belfast BT9 7AE, Northern Ireland, UK.
Arkady KhoutorskyDepartment of Anesthesia and Alan Edwards Centre for Research on Pain, McGill University, Montréal H3A 0G1, Canada.
Christos G GkogkasBiomedical Research Institute, Foundation for Research and Technology-Hellas, University Campus, 45110 Ioannina, Greece.ORCID 0000-0001-6281-3419
McGill University · CAFoundation for Research and Technology Hellas · GRUniversity of Edinburgh · GBQueen's University Belfast · GBInnsbruck Medical University · ATInstitute for Research in Immunology and Cancer · CAMRC Laboratory for Molecular Cell Biology · GBUniversity of Minnesota, Duluth · US

Funding

Integrated stress response and the circadian clockR01GM143260 · NIGMS · UNIVERSITY OF MINNESOTA · PI CAO, RUIFENG (RAY) · 2022 to 2025
$1.4M
Wellcome Trust
6 · The paper itself

Abstract

MAPK interacting protein kinases 1 and 2 (Mnk1/2) regulate a plethora of functions, presumably via phosphorylation of their best characterized substrate, eukaryotic translation initiation factor 4E (eIF4E) on Ser209. Here, we show that, whereas deletion of Mnk1/2 (Mnk double knockout) impairs synaptic plasticity and memory in mice, ablation of phospho-eIF4E (Ser209) does not affect these processes, suggesting that Mnk1/2 possess additional downstream effectors in the brain. Translational profiling revealed only a small overlap between the Mnk1/2- and phospho-eIF4E(Ser209)-regulated translatome. We identified the synaptic Ras GTPase activating protein 1 (Syngap1), encoded by a syndromic autism gene, as a downstream target of Mnk1 because Syngap1 immunoprecipitated with Mnk1 and showed reduced phosphorylation (S788) in Mnk double knockout mice. Knockdown of Syngap1 reversed memory deficits in Mnk double knockout mice and pharmacological inhibition of Mnks rescued autism-related phenotypes in Syngap1+/- mice. Thus, Syngap1 is a downstream effector of Mnk1, and the Mnks-Syngap1 axis regulates memory formation and autism-related behaviours.

Indexed as

Autistic DisorderEukaryotic Initiation Factor-4EAnimalsMiceMice, KnockoutPhosphorylationProtein Serine-Threonine Kinasesras GTPase-Activating ProteinsEukaryotic Initiation Factor-4EMknk1 protein, mouseMknk2 protein, mouseProtein Serine-Threonine Kinasesras GTPase-Activating ProteinsSyngap1 protein, mouseautismlearningmemoryphosphorylationsynaptic translationtranslational control

Identifiers

PMID36315645
PMCPMC10411928
OpenAlexW4307889735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.